Home>Bulk Products>Methyl 3-(bromomethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

About Us

Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.


With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.

Qualifications

DUNS: 560440352

BD460648[1256388-92-7]Methyl 3-(bromomethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate*

Specific Information

Purity : 95% Specific Rotation :
NMR(H/C/F/S/P) : E.E. :
HPLC : Water Content :
Polymerization Inhibitor : Single Impurity :
Melting Point : Density :
Packaging : Solubility :
Name Note : Acetic Acid :
Beilstein : Grade :
Specific Gravity : Viscosity :
Others :

Product Details

Cat No. : BD460648 Synonyms : Methyl 3-(bromomethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
CAS No. : 1256388-92-7 MDL NO : MFCD18383438
Formule : C15H20BBrO4 InChI Key : N/A
M.W : 355.03 Pubchem ID : 59610334
Boiling Point :

Safety

Signal Word : Danger Class : 6.1
Precautionary Statements : P201-P202-P261-P264-P270-P271-P280-P302+P352-P304+P340-P308+P313-P310-P330-P361-P403+P233-P405-P501 UN# : 2810
Hazard Statements : H301-H311-H331-H341 Packing Group :
GHS Pictogram:

R&D Center